United-Guardian, Inc.
Index- P/E20.85 EPS (ttm)0.95 Insider Own36.76% Shs Outstand4.59M Perf Week9.40%
Market Cap98.16M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.91M Perf Month-20.20%
Income4.40M PEG- EPS next Q- Inst Own25.30% Short Float0.14% Perf Quarter2.05%
Sales14.40M P/S6.82 EPS this Y41.00% Inst Trans0.81% Short Ratio0.25 Perf Half Y17.67%
Book/sh2.34 P/B8.51 EPS next Y- ROA34.30% Target Price- Perf Year19.22%
Cash/sh1.58 P/C12.58 EPS next 5Y- ROE40.90% 52W Range13.68 - 26.09 Perf YTD21.03%
Dividend1.50 P/FCF75.50 EPS past 5Y12.50% ROI45.40% 52W High-28.78% Beta0.19
Dividend %7.53% Quick Ratio5.40 Sales past 5Y5.30% Gross Margin57.60% 52W Low35.83% ATR1.58
Employees22 Current Ratio6.10 Sales Q/Q14.70% Oper. Margin40.00% RSI (14)45.74 Volatility12.32% 8.67%
OptionableNo Debt/Eq0.00 EPS Q/Q-22.80% Profit Margin30.50% Rel Volume0.06 Prev Close19.91
ShortableYes LT Debt/Eq0.00 EarningsMar 18 BMO Payout118.30% Avg Volume16.12K Price18.58
Recom- SMA20-2.26% SMA50-11.35% SMA2007.28% Volume143 Change-6.67%
May-15-22 08:20AM  
May-12-22 09:00AM  
Mar-17-22 09:00AM  
Feb-09-22 10:29AM  
Jan-25-22 09:00AM  
Dec-27-21 12:25PM  
Nov-21-21 06:42AM  
Nov-18-21 09:00AM  
Nov-17-21 01:32PM  
Nov-10-21 10:56AM  
Oct-05-21 01:38PM  
Aug-20-21 03:43PM  
Aug-11-21 09:00AM  
Jul-12-21 12:57PM  
Jun-29-21 09:35AM  
May-20-21 11:16AM  
May-12-21 09:00AM  
Apr-13-21 07:48AM  
Mar-19-21 09:00AM  
Feb-24-21 04:52AM  
Jan-03-21 04:34PM  
Dec-25-20 04:52AM  
Nov-25-20 03:28AM  
Nov-20-20 11:00AM  
Nov-10-20 11:00AM  
Oct-23-20 03:00PM  
Oct-22-20 01:27PM  
Sep-16-20 02:48PM  
Sep-01-20 11:43AM  
Aug-07-20 10:00AM  
Jul-15-20 02:15PM  
Jul-10-20 01:39PM  
Jun-04-20 04:16AM  
May-21-20 12:01PM  
May-20-20 12:37PM  
May-19-20 02:23AM  
May-18-20 09:08AM  
May-13-20 09:00AM  
Apr-22-20 11:59AM  
Mar-19-20 09:00AM  
Mar-17-20 01:15PM  
Mar-13-20 03:01PM  
Feb-26-20 01:46AM  
Feb-19-20 11:08AM  
Feb-09-20 05:53PM  
Jan-20-20 01:58PM  
Jan-13-20 06:34AM  
Dec-23-19 01:40PM  
Dec-18-19 09:31AM  
Nov-27-19 05:18AM  
Nov-25-19 07:16PM  
Nov-22-19 09:00AM  
Nov-08-19 09:00AM  
Oct-31-19 03:01PM  
Oct-30-19 02:28PM  
Oct-23-19 01:50AM  
Oct-03-19 01:50PM  
Sep-06-19 08:36AM  
Aug-14-19 08:43AM  
Aug-09-19 09:00AM  
Jul-25-19 10:00AM  
Jul-08-19 03:49PM  
Jun-22-19 10:54AM  
Jun-05-19 11:46AM  
May-20-19 07:47AM  
May-17-19 09:00AM  
May-09-19 09:00AM  
May-03-19 01:30PM  
Apr-10-19 12:53PM  
Mar-21-19 09:00AM  
Mar-18-19 12:29PM  
Feb-18-19 03:42PM  
Jan-23-19 07:01AM  
Dec-02-18 08:11AM  
Nov-29-18 09:47AM  
Nov-13-18 08:30AM  
Nov-12-18 11:01AM  
Nov-08-18 09:40AM  
Oct-17-18 01:32PM  
Sep-11-18 01:01PM  
Aug-08-18 09:57AM  
Jul-24-18 03:53AM  
Jun-24-18 10:15AM  
May-31-18 10:40PM  
May-24-18 09:36PM  
May-18-18 09:00AM  
May-10-18 09:11AM  
United-Guardian, Inc. manufactures and markets cosmetic ingredients, pharmaceuticals, medical lubricants, and proprietary specialty industrial products in the United States and internationally. The company offers cosmetic ingredients, including LUBRAJEL line of water-based moisturizing and lubricating gel formulations; LUBRAJEL NATURAL consisting of natural ingredients for cosmetic use; LUBRAJEL MARINE; LUBRASIL II SB, a special formulation of LUBRAJEL in which silicone oil is incorporated into a LUBRAJEL base; LUBRAJEL II XD; B-122, a powdered lubricant that is used in the manufacture of pressed powders, eyeliners, rouges, and industrial products; KLENSOFT, a surfactant, which is used in shampoos, shower gels, makeup removers, and other cosmetic formulations; and ORCHID COMPLEX, an oil-soluble base for skin creams, lotions, cleansers, and other cosmetics. Its medical lubricants comprise LUBRAJEL RR and RC, which are water-based lubricant gels for urinary catheters; LUBRAJEL MG to lubricate urinary catheters, pre-lubricated enema tips, and other medical devices; LUBRAJEL LC and LUBRAJEL FA that are LUBRAJEL formulations for oral care; and LUBRAJEL FLUID to lubricate water-soluble products. The company's pharmaceutical products consist of RENACIDIN, a prescription drug to prevent and dissolve calcifications in urethral catheters and the urinary bladder; and CLORPACTIN WCS-90, an antimicrobial product to treat infections in the urinary bladder, and localized infections in the peritoneum, as well as eye, ear, nose and throat, and sinuses. Its industrial products include DESELEX, a sequestering and chelating agent used for manufacturing detergents; and THOROCLENS, a chlorine-based industrial cleanser. The company also conducts research and development primarily related to the development of cosmetic ingredients. It markets its products through marketing partners, distributors, and wholesalers. The company was founded in 1942 and is based in Hauppauge, New York.